Choose New Jersey will showcase top life sciences companies, universities, trade associations, the State government at its New Jersey Pavilion (Booth #1737) at BIO International 2017, which will be held from June 19 to 22 at the San Diego Convention Center.
During the convention, the New Jersey delegation will meet with business executives from life science-based organizations — from around the United States as well as the globe — interested in learning what makes the Garden State an ideal place to start or relocate their operations.
In 2015, 53 percent of FDA approvals came from companies with a New Jersey footprint, and 26 percent of the products in the State’s drug pipeline are in Phase III trials, compared to 16 percent for the industry as a whole.
New Jersey’s world-class universities have a long history of discovering unique technologies and collaboration with the private sector.
For information about or to register for Choose New Jersey’s June 19 reception, please contact (no later than June 14) Jay Hertz at firstname.lastname@example.org or 609-297-2202.
For information about BIO International 2017, click here.
To learn more about the life sciences’ economic impact on New Jersey, visit HINJ’s “New Jersey’s Life Sciences: By the Numbers.”
Choose New Jersey, Inc. is a privately funded 501(c)(3) corporation charged with encouraging and nurturing economic growth throughout New Jersey with a focus on its urban centers.
Through marketing, business attraction and lead generation activities, Choose New Jersey markets New Jersey as a premiere business location to both domestic and international businesses.
Choose New Jersey is a member of the Partnership for Action (PFA), which is led by Lt. Governor Kim Guadagno and also includes the New Jersey Business Action Center, the New Jersey Economic Development Authority and the Office of the Secretary of Higher Education.
The Healthcare Institute of New Jersey (HINJ) has served as the voice for the state’s life sciences industry since its founding in 1997. HINJ seeks to expand patient access to the most innovative biopharmaceuticals and medical devices and promote awareness of the industry’s impact on New Jersey’s quality of life and economic well-being.
The Biotechnology Innovation Organization (BIO), headquartered in Washington, DC, is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.